| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1cd8c26e69263bbbd1f8bd74a4019e50 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-124 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate |
2013-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02d137e9e4d40de9ae35d178f17288c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55f4d492445d80ea7cdba6e85519e00e |
| publicationDate |
2013-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2013166803-A |
| titleOfInvention |
Infarct region perfusion improving composition and method of repairing vascular injury |
| abstract |
The present invention provides a pharmaceutical composition for treating infarct area damage and a method for treating or repairing infarct area damage in the aftermath of acute myocardial infarction resulting from normal disease processes in a revascularization target animal. The method is performed by administering a sterile pharmaceutical composition parenterally to a subject animal via a catheter, wherein the sterile pharmaceutical composition is sterile, not grown as a first therapeutic agent. A therapeutically effective amount of the isolated chemotactic hematopoietic stem cell product and optionally a therapeutically effective amount of at least one compatible second therapeutic agent. The infarct area improvement amount of the sterile isolated chemotactic hematopoietic stem cell product includes an enriched population of autologous isolated CD34 + cells, and the enriched population is enriched in autologous isolated CD34 + hematopoietic stem cells. Express CXCR-4 and further CXCR-4 so that the population can provide at least 0.5 × 10 6 competent CD34 + cells that express CXCR-4 and further have CXCR-4 mediated chemotactic activity. Includes a subpopulation of competent cells with mediated chemotactic activity. [Selection figure] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016529313-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014037433-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020011986-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013508408-A |
| priorityDate |
2008-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |